This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.1g, 0.25g, 1g, 5g
Available purity: >95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1369862-03-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.1g
>95%
0
Out of Stock
Shanghai
Inquiry
0.25g
>95%
0
Out of Stock
Shenzhen
Inquiry
1g
>95%
0
Out of Stock
Hong Kong
Inquiry
5g
>95%
0
Out of Stock
Beijing
Inquiry
1369862-03-2 / 2-azatricyclo[10.4.0.04,9]hexadeca-1(16),4,6,8,12,14-hexaen-10-yne
Standard CAS: 1369862-03-2
Multi CAS: No
Basic Information
copy
CAS
1369862-03-2 copy
Multi CAS
No copy
Molecular Formula
C15H11N copy
Molecular Weight
205.250000 copy
Exact Mass
205.089149 copy
SMILES
C1C2=CC=CC=C2C#CC3=CC=CC=C3N1 copy
InChI
InChI=1S/C15H11N/c1-2-7-14-11-16-15-8-4-3-6-13(15)10-9-12(14)5-1/h1-8,16H,11H2 copy
InChIKey
ZTSQAEKXARSKNC-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
16 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.07 copy
H-bond acceptors
1 copy
H-bond donors
1 copy
Molar refractivity
66.19 copy
TPSA
12.03 copy
LogP / Solubility
WLOGP
3.01 copy
MLOGP
2.65 copy
XLogP3
3 copy
Consensus LogP
2.89 copy
Log S (ESOL)
-3.57 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.42 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.49 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.83 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy